RPE65 is the isomerohydrolase in the retinoid visual cycle essential for recycling of 11-cis retinal, the chromophore for visual pigments in both rod and cone photoreceptors. Mutations in the RPE65 gene are associated with inherited retinal dystrophies with unknown mechanisms. Here we show that two point mutations of RPE65, R91W and Y368H, identified in patients with retinal dystrophies both abolished the isomerohydrolase activity of RPE65 after a subretinal injection into the Rpe65 ؊/؊ mice and in the in vitro isomerohydrolase activity assay, independent of their protein levels. Further, the R91W and Y368H mutants showed significantly decreased protein levels but unchanged mRNA levels when compared with the wild-type RPE65 (wtRPE65). Protein stability analysis showed that wtRPE65 is a fairly stable protein, with an apparent half-life longer than 10 h, when expressed in 293A cells. Under the same conditions, mutants R91W and Y368H both showed substantially decreased protein stabilities, with half-lives less than 2 and 6 h, respectively. Subcellular fractionation and Western blot analysis demonstrated that wtRPE65 predominantly exists in the membrane fraction, while both of the mutants are primarily distributed in the cytosolic fraction, suggesting that these mutations disrupt the membrane association of RPE65. However, palmitoylation assay showed that wtRPE65 and both of the mutants were palmitoylated. These results suggest that these mutations may result in critical structural alterations of RPE65 protein, disrupt its membrane association, and consequently impair its isomerohydrolase activity, leading to retinal degeneration.
Both rod and cone visual pigments in vertebrates require 11-cis retinal as the chromophore (1, 2) . Photoisomerization of 11-cis retinal to all-trans retinal by photon triggers the phototransduction cascade and initiates vision (3) (4) (5) . Recycling of 11-cis retinal through the retinoid visual cycle is essential for the regeneration of visual pigments and for normal vision.
RPE65 is a membrane-associated protein predominantly expressed in the retinal pigment epithelium (RPE) 3 (6) . RPE65 knock-out (Rpe65 Ϫ/Ϫ ) mice showed an impaired visual function and early cone photoreceptor degeneration (7, 8) . Several groups have independently identified multiple mutations in the RPE65 gene from patients with inherited retinal dystrophies (9 -23) . It has been shown that mutations in the RPE65 gene account for 2% of cases of autosomal recessive retinitis pigmentosa (ARRP) and 16% of Leber congenital amaurosis (LCA) (15) . To date, not only nonsense mutations (null mutants) but also more than 30 missense mutations in the RPE65 gene have been identified in patients with inherited retinal dystrophies (9 -21, 23) . These findings indicate that RPE65 is essential for normal vision.
The RPE65 gene has been cloned from 11 species of vertebrates. Human RPE65 shares more than 93% of amino acid sequence identities to its counterparts from other mammalians and more than 73% of identities to those from chicken, zebra fish, and several amphibians (6, 24 -31) . The highly conserved primary structure of RPE65 across all vertebrates suggests that RPE65 has an important physiological function. The only genes in the entire GenBank TM that share significant sequence homology with RPE65 are those encoding enzymes in the ␤-carotene monooxygenase family (32) (33) (34) .
As Rpe65 Ϫ/Ϫ mice lack 11-cis retinal and overaccumulate all-trans retinyl esters, it is commonly believed that RPE65 plays an important role in the generation of 11-cis retinal in the visual cycle, possibly at the step of isomerization of all-trans retinyl ester to 11-cis retinol. Recently, we and other groups have provided direct evidence indicating that RPE65 is the isomerohydrolase, an enzyme catalyzing the isomerization and hydrolysis of all-trans retinyl ester to 11-cis retinol in the visual cycle (35) (36) (37) .
Although multiple mutations in the RPE65 gene have been identified in patients with inherited retinal dystrophies, the molecular pathogenesis for the retinal degeneration associated with the RPE65 missense mutations has not been elucidated. Here, we investigated the impacts of two missense point mutations, R91W and Y368H, common in patients with retinal dystrophies (12, 15, 19, 23) , on expression, stability, subcellular localization, and enzymatic activity of RPE65.
EXPERIMENTAL PROCEDURES

Construction of RPE65 Expression Vector and Site-directed
Mutagenesis-The full-length human RPE65 cDNA was subcloned into the pBluescript SK(ϩ) vector. Mutations R91W and Y368H were generated using the QuikChange site-directed mutagenesis kit (Stratagene, La Jolla, CA) following the protocol recommended by the manufacturer. The sequences of the mutants were confirmed from both directions using ABI-3730 DNA sequencer (Applied Biosystems, Foster City, CA) and subcloned into a transfer vector, pShuttle-CMV (Stratagene). The pShuttle-CMV vectors carrying wtRPE65 and its mutants, R91W and Y368H, were linearized with PmeI, and transformed into BJ5183-AD1 (Stratagene) to generate recombinant adenovirus DNA. The recombinant adenovirus DNA was linearized with PacI and transfected into QBI-293A cells (Qbiogene, Carlsbad, CA) for adenovirus packaging using FuGENE6 (Roche, Indianapolis, IN) as recommended by the manufacturer. The recombinant adenoviruses were verified by PCR followed by DNA sequencing from both directions. Furthermore, the gene expression from adenovirus vectors was confirmed by Western blot analysis using an anti-RPE65 antibody (38) . Generated adenoviruses were amplified and titered using the plaque-forming assay (plaques-forming unit per ml, PFU/ml) by VectorBioLabs (Philadelphia, PA).
Co-expression of LRAT with wtRPE65 or Its Mutants in QBI-293A Cells-QBI-293A cells were cultured in Dulbecco's modified Eagle's medium supplemented 5% fetal bovine serum in 15-cm dishes until 65-75% confluent. The human LRAT cDNA in the pcDNA6 vector was transfected into the QBI-293A cells. Twenty-four hours following the transfection, the cells were infected separately with Ad-wtRPE65, Ad-R91W, and Ad-Y368H at multiplicity of infection (MOI, the ratio of virus pfu to cell number) of 20 or MOI of 250 and cultured for another 24 h. The cells were harvested and stored in the Ϫ80°C freezer until they were used.
Isomerohydrolase Activity Assay-QBI-293A cells co-expressing LRAT and wtRPE65, or R91W or Y368H were lysed in a buffer containing 10 mM BTP (Bis-Tris propane, pH 8.0). Uninfected QBI-293A cells were used as a negative control. Cell lysates were sonicated on ice for 20 s in a reaction buffer (10 mM BTP, pH 8.0, 100 mM NaCl) and the total cell lysate was used for activity assays. All-trans [11,12- 3 H]retinol in ethanol (1 mCi/ ml, 52 Ci/mmol, Perkin Elmer, Boston, MA) was dried under argon and resuspended in the same volume of dimethyl formamide (DMF). For each reaction, 2 l of the non-diluted alltrans [11, H]retinol in DMF and 250 g of total cell lysate were added into 200 l of the reaction buffer containing 0.5% bovine serum albumin and 25 M CRALBP (cellular retinaldehyde-binding protein). After a 2-h incubation in the dark at 37°C, retinoids generated were extracted by the addition of 300 l of cold methanol and 300 l of hexane. The upper organic phase was collected and analyzed by normal phase HPLC as described (39) . The peak of each retinoid isomer was identified based on retinoid standards. The isomerohydrolase activity was calculated from the area of 11-cis retinol peak using Radiomatic 610TR software (PerkinElmer) with synthetic 11-cis [ 3 H]retinol as a standard. For the mouse eyecups, the assay was performed using 250 g of eyecup homogenate.
Quantitative Real-time RT-PCR-Total RNA was isolated from cells using RNeasy (Qiagen, Valencia, CA) and treated with RNase free DNase-I (Invitrogen, Carlsbad, CA) to remove viral DNA contaminations before reverse transcription. Each PCR included a negative control which omitted reverse transcriptase to exclude possible amplification from viral DNA contaminations. The primers for real-time PCR span large introns in the RPE65 gene to avoid amplification from possible genomic DNA contaminations. Quantitative PCR reactions were performed with iQ SYBR Green supermix (Bio-Rad) following manufacturer's protocol, and the signals were detected using MyiQ single color real-time detection system (Bio-Rad). The data were analyzed with the MyiQ data analyzing software (Bio-Rad) and Microsoft Excel. The PCR products were visualized with 2% of agarose gel electrophoresis to ensure that the PCR reactions amplified only single products of 173 bp.
Subretinal Injection of Adenovirus Carrying wtRPE65, R91W, and Y368H into Rpe65
Ϫ/Ϫ Mice-Subretinal injection was performed in Rpe65 Ϫ/Ϫ mice at 2 weeks of age. Briefly, mice were anesthetized with a 50:50 mix of ketamine (100 mg/ml) and xylazine (20 mg/ml), and the pupils were dilated with topical phenylephrine (2.5%) and tropicamide (1%). A sclerotomy was made ϳ0.5-mm posterior to the limbus with a blade; a glass injector connected to a syringe filled with 3 l of virus was introduced through the sclerotomy area into the vitreous cavity. The tip of the injector was introduced into the subretinal space through a peripheral retinotomy, and the virus was slowly injected. A gray bubble demonstrated that the virus was delivered into the expected site and retina was detached from the RPE.
Subcellular Fractionation of Cultured Cells-The 293A cells expressing RPE65 or its mutants were washed twice with icecold phosphate-buffered saline, separated into cytosolic, membrane, nuclear, and cytoskeletal fractions using FractPrep TM (BioVision, Mountain View, CA) following the manufacturer's protocol. The same amount of proteins (8 g) on each fraction was resolved by 8% SDS-PAGE and analyzed by Western blot analysis using a purified RPE65 antibody (38) to confirm their subcellular localization.
Protein Stability Assays-To determine the half-lives of wtRPE65 and its mutants, QBI-293A cells were cultured in Dulbecco's modified Eagle's medium supplemented with 5% fetal bovine serum until 65-75% confluent and then infected with the virus at MOI of 10. The recombinant RPE65 and its mutants were allowed to express for 18 h. The protein synthesis was then stopped by addition of 25 g/ml of cycloheximide (CHX; Sigma). The cells were harvested at 0, 2, 6, and 10 h following the addition of CHX. The expression levels of the proteins were confirmed by Western blot analysis and semiquantified with densitometry. Apparent half-lives were averaged from four independent experiments and expressed as mean Ϯ S.D.
Palmitoylation Assay-QBI-293A cells were separately infected by Ad-wtRPE65 (MOI ϭ 100), Ad-R91W (MOI ϭ 400), and Ad-Y368H (MOI ϭ 400). The infected cells were incubated for 2 h, followed by the addition of 6 mCi of [9, H]palmitic acid (American Radiolabeled Chemical, Inc., St. Louis, MO), and incubated for another 16 h. The cells were harvested by cell scraper, washed twice with phosphate-buffered saline, and then lysed by sonication. Expressed wtRPE65 and its mutants were purified by immunoprecipitation. Briefly, same amounts of total cell lysates (1.3 mg) were dissolved by phosphate-buffered saline containing 0.3% CHAPS and 1 g/ml aprotinin, 1 g/ml leupeptin, and 100 M phenylmethylsulfonyl fluoride for 1.5 h on ice. Solubilized fraction by CHAPS was separated by centrifugation, and gently mixed with cyanogen bromide-activated Sepharose 4B (Amersham Biosciences) conjugated with the antibody for human RPE65 in cold room overnight. The Sepharose was washed five times by phosphate-buffered saline containing 0.3% CHAPS and proteinase inhibitors described above. The final elution was performed by addition of SDS-PAGE sample buffer. Purified wtRPE65 and its mutants were separated in the 8% SDS-PAGE gel. The gel was treated with Amplify TM reagent (Amersham Biosciences) according to manufacturer's protocol and dried using gel dryer. The dried gel was exposed to Kodak Biomax MS (Kodak, Rochester, NY) in an autoradiography cassette Ϫ80°C for 8 days, and the film was then developed.
RESULTS
Gene Delivery of Ad-R91W or Ad-Y368H Fails to Restore Isomerohydrolase Activity in Rpe65
Ϫ/Ϫ Mice-Ad-wtRPE65, Ad-R91W, and Ad-Y368H were separately injected into the subretinal space of Rpe65 Ϫ/Ϫ mice at 2 weeks of age. Two weeks following the injection, mice were sacrificed, and their eyecups were dissected and homogenized individually as described under "Experimental Procedures." The eyecups of untreated wt mice (sv129) at the same age (4 weeks after birth) were prepared as the positive control. The same amount of total eyecup protein (250 g) from each mouse was used for in vitro isomerohydrolase activity assay. Incubation of all-trans [
3 H]retinol with eyecup proteins from sv129 mice generated a peak of 11-cis [ 3 H]retinol (Fig. 1A) , whereas the same amount of eyecup protein from Rpe65 Ϫ/Ϫ mice did not generate any 11-cis retinol (Fig. 1B) (Fig. 1C) , demonstrating that Ad-wtRPE65 injection restored isomerohydrolase activity in Rpe65 Ϫ/Ϫ mice. Under the same conditions, however, mice injected with Ad-R91W (Fig. 1D) or Ad-Y368H (Fig.  1E) did not exhibit any detectable isomerohydrolase activities.
Mutations R91W and Y368H Decrease the Protein Level but Not the mRNA Level of RPE65-To study the impact of the point mutations, R91W and Y368H, on RPE65 expression, we have infected QBI-293A cells with the same titer of Ad-wtRPE65, Ad-R91W, or Ad-Y368H. Twenty-four hours following the infection, the cells were harvested and homogenized. The same amount of total cellular protein was blotted with the anti-RPE65 antibody. The result showed that both of the RPE65 mutants had substantially lower protein abundance than that of wtRPE65 in the infected cells ( Fig. 2A) .
To elucidate the mechanism responsible for the decreased protein levels of the R91W and Y368H mutants, we compared their mRNA levels. QBI-293A cells, which were separately infected by the same titer (MOI ϭ 20) of Ad-wtRPE65, Ad-R91W, and Ad-Y368H were harvested 18 h following the adenoviral infections. The mRNA levels were measured using quantitative real-time RT-PCR. After normalization by mRNA levels of a housekeeping gene, glyceraldehyde-3-phosphate dehydrogenase, there was no significant difference in the mRNA levels between wtRPE65, R91W, and Y368H ( p Ͼ 0.1, n ϭ 3) (Fig. 2B) . The amplified PCR product showed a single band with the expected size (173 bp) only from the infected cells as shown by the agarose gel electrophoresis (Fig. 2C) . The PCR product was not amplified from contamination of viral DNA, as the negative control RT-PCR without reverse transcriptase did not generate any detectable PCR product (Fig. 2B) , demonstrating specificity of the RT-PCR.
Mutations R91W and Y368H Decrease RPE65 Protein Stability-To determine if the mutations affect the protein stability, QBI-293A cells were separately infected with AdwtRPE65, Ad-R91W, and Ad-Y368H at MOI of 10. The protein expression was allowed for 18 h and then blocked by the addition of 25 g/ml CHX. The cells were harvested at 0, 2, 6, and 10 h after the addition of CHX, and the protein levels of wtRPE65 and its mutants were measured by Western blot analysis and semiquantified using densitometry. WtRPE65 showed a high stability, with a half-life more than 10 h in 293A cells (Fig.   FIGURE 1. 
Isomerohydrolase activities in the Rpe65
؊/؊ mouse eyecups after a subretinal injection of Ad-wtRPE65, Ad-R91W, or Ad-Y368H. Eyecups from Rpe65 Ϫ/Ϫ mice after a subretinal injection of Ad-wtRPE65, Ad-R91W, or Ad-Y368H were homogenized. The same amount of eyecup protein from each mouse was incubated with all-trans [ 3 H]retinol for 2 h, and the generated 3 H retinoids were analyzed by HPLC. Wt sv129 mice (A) and Rpe65 Ϫ/Ϫ mice without injection (B) were used as positive and negative controls, respectively. Ad-wtRPE65 injection generated robust isomerohydrolase activity in Rpe65 Ϫ/Ϫ eyecups (C), while injections of the same titer of Ad-R91W (D) and Ad-Y368H (E) did not generate any detectable isomerohydrolase activity. Peak 1, retinyl esters; peak 2, all-trans retinal, peak 3, 11-cis retinol; peak 4, 13-cis retinol, peak 5, all-trans retinol.
3). In contrast, the R91W and Y368H mutants exhibited significantly accelerated degradation under the same conditions, with apparent half-lives less than 2 and 6 h, respectively (Fig. 3) , suggesting that these single point mutations decrease the stability of RPE65.
Mutations R91W and Y368H Alter the Subcellular Localization of RPE65 Protein-Furthermore, we examined subcellular localization of wtRPE65 and its mutants in the infected QBI-293A cells. Cells infected with Ad-wtRPE65, Ad-R91W, and Ad-Y368H were fractionated. The wtRPE65 protein was found at a high level in the membrane fraction and a relatively low level in the cytosolic fraction, consistent with previous findings that RPE65 exists in a membrane associated form and a cytosolic form (38, 40) (Fig. 4) . In contrast, the two RPE65 mutants predominantly exist in the cytosolic fraction, with low levels in the membrane fraction, suggesting that these mutations disrupt the membrane association of RPE65 (Fig. 4) . The mutant proteins detected in the cytoskeletal/inclusion body fraction may be a result of the formation of inclusion bodies, as the proteins in this fraction resisted the solubilization by the detergent provided from the fractionation kit.
Mutations R91W and Y368H Impair Enzymatic Activity of RPE65-As RPE65 has been recently found to be the isomerohydrolase in the visual cycle (35-37), we have measured the impact of these mutations on the enzymatic activity of RPE65. For the enzymatic activity assay, we co-expressed LRAT with RPE65 in 293A cells, as we have shown that LRAT expression in the same cells is essential for the enzymatic activity of RPE65 (35) . Total homogenates from QBI-293A cells co-expressing LRAT and wtRPE65 or its mutants were used for the in vitro isomerohydrolase activity assay. In the cells infected with the same titer of adenovirus expressing the wtRPE65 and its mutants (MOI of 20), wtRPE65 generated significant amounts of 11-cis retinol from all-trans retinol (Fig. 5, C and D) , whereas both mutants did not show any detectable isomerohydrolase activity after the infection with the same titer of viruses as Ad-RPE65 (Fig. 5, E and F) . To exclude the possibility that the lack of enzymatic activity of the RPE65 mutants may be ascribed to their lower protein abundance in the infected 293A cells, as demonstrated by Western blot analysis (Fig. 5, A and B) , we infected the cells with higher titers of Ad-R91W and Ad-Y368H (MOI ϭ 250). The high titer viral infection generated mutant protein levels comparable to that in the cells infected by AdwtRPE65 at MOI of 20 ( Fig. 5A ). At these high levels of expression, however, the mutants R91W and Y368H still showed no detectable isomerohydrolase activity (Fig. 5, G and H) , suggesting that the lack of enzymatic activity in the RPE65 mutants cannot be ascribed to their decreased protein levels.
Mutants R91W and Y368H Are Palmitoylated-As it has been suggested that palmitoylation at three Cys residues in RPE65 may be responsible for its membrane association (40), we have examined the impacts of the mutations on palmitoylation of RPE65. We have performed a palmitoylation assay to examine the palmitoylation status of wtRPE65 and the mutants expressed in 293A cells. The results showed that wtRPE65 and both of the mutants are palmitoylated (Fig. 6) . However, palmitoylation levels of the mutants were significantly lower than that of wtRPE65. After normalization by RPE65 levels based on Western blot analysis, palmitoylation levels in R91W and Y368H were 38 Ϯ 10 and 48 Ϯ 4% of that in wtRPE65, respectively, possibly because of RPE65 structure distortions introduced by these mutations.
DISCUSSION
Mutations in the RPE65 gene are associated with inherited retinal dystrophies (9 -21,23) . The mechanisms for these mutations, especially the missense mutations, to lead to retinal degeneration and impaired vision have not been understood, . Palmitoylation assay of wtRPE65 and its mutants. QBI-293A cells were separately infected by Ad-wtRPE65 at MOI of 100, and by Ad-R91W and Ad-Y368H at MOI of 400. Then 6 mCi of [9,10- 3 H]palmitic acid was added to the culture medium 2 h after the viral infection. The cells were then cultured for another 16 h, harvested by cell scraper and washed twice by phosphatebuffered saline. Recombinant RPE65 and its mutants were affinity-purified. A, palmitoylation was analyzed by autoradiography. B, same purified proteins of wtRPE65 and its mutants were semiquantified by Western blot analysis. C, palmitoylation was normalized by relative RPE65 protein levels based on Western blot analysis and the normalized palmitoylation levels were expressed as % of wt (mean Ϯ S.D., n ϭ 3).
mainly because the function of RPE65 was unknown. Recent evidence has shown that RPE65 is the isomerohydrolase converting all-trans retinyl ester to 11-cis retinol (35) (36) (37) , and thus, opened a way to study the impact of the patient mutations on the structure and function of this important enzyme. The present study reports the impacts of two point mutations of RPE65 from patients with retinal dystrophies on the stability and function of RPE65. The results demonstrate that R91W and Y368H mutations both decrease the stability and change the subcellular localization of the RPE65 protein. Moreover, these mutations also impair the enzymatic activity of RPE65.
RPE65 is an abundant protein in the RPE, with 11 g of RPE65 protein per bovine RPE (38) . Our recent studies showed that the high abundance of this enzyme is necessary for compensating its weak enzymatic activity (35) . The turnover rate of RPE65 has not been determined previously. Here we show that RPE65 is a fairly stable protein, with an apparent half-life longer than 10 h. The high stability and low degradation rate may result in the accumulation of RPE65 and may be responsible for its high abundance in the RPE. Single point mutations R91W and Y368H both decrease protein levels, but do not affect the mRNA level of RPE65, suggesting that the decreases of the mutant protein levels may occur at the translational or posttranslational levels. Protein stability assay showed that missense mutations R91W and Y368H significantly decrease the half-life of RPE65. This result suggests that the accelerated protein degradation in the RPE65 mutants may be responsible, at least in part, for their lower protein levels. The shorter half-lives of these RPE65 mutants can result in interrupted visual cycle, which may explain why these point mutations impair normal vision in patients with ARRP and LCA (12, 15, 19, 23) .
As the three-dimensional structure of RPE65 protein has not been revealed, it is presently unclear how these point mutations destabilize RPE65. Previous studies have shown that wtRPE65 exists in two forms, a membrane associated form and a cytosolic form (38) . Our data showed that both mutants are predominantly located in the cytosolic fraction, in contrast to the localization of wtRPE65 predominantly in the membrane fraction. The mislocalization may be responsible for the accelerated degradation of the mutant proteins. As it has been reported that RPE65 possesses three palmitoylation sites (cysteine residues), and palmitoylation may be responsible for its membrane association (40), we examined the palmitoylation status of the mutants. Our palmitoylation assay showed that similar to wtRPE65, both of the mutants were palmitoylated, but at lower levels, compared with that of wtRPE65 (Fig. 6) . It remains to be determined if the decreased palmitoylation or the RPE65 structure distortion introduced by these mutations is responsible for the dissociation of the RPE65 protein from the membrane and abolished enzymatic activity. A recent study showed that RPE65 peptide fragments amino acids 1-125 and amino acids 126 -250 are relatively hydrophobic and interact with lipid monolayer even in the absence of palmitoylation (41) . This result suggests that RPE65 may bind to the membrane through other mechanisms, such as hydrophobic interactions between the membrane and the hydrophobic domains of RPE65. The two point mutations of RPE65 analyzed here may disrupt the hydrophobic interactions between these hydrophobic domains and the membrane, because of possible structure distortions.
We and other groups recently showed that RPE65 is the isomerohydrolase which catalyzes the conversion of all-trans retinyl ester to 11-cis retinol (35) (36) (37) . The present study showed that R91W and Y368H both abolish isomerohydrolase activity of RPE65. To exclude the possibility that the lack of the enzymatic activity of the RPE65 mutants may be solely ascribed to the lower protein levels of the mutant proteins, we have overexpressed the mutant proteins using a very high titer of the recombinant virus for infection and expression of the mutant proteins. After achieving the mutant protein levels comparable to that of wtRPE65, however, the mutants still lack any detectable isomerohydrolase activity. This observation suggests that these mutations not only destabilize RPE65 protein, but also abolish the enzymatic activity, possibly because of misfolded structures of RPE65 protein. Our recent studies demonstrated that the membrane association of RPE65 is essential for it to obtain hydrophobic all-trans retinyl ester, its direct substrate, through the hydrophobic membrane (39) , and thus essential for its isomerohydrolase activity. The disrupted membrane association of the RPE65 mutants may be responsible for the abolished activity of these mutants. The mutants may also affect the RPE65 conformation which is essential for its enzymatic activity or substrate binding. Another possibility is that Arg 91 and Tyr 368 may serve as key residues in the reactive site of the enzyme. Therefore, this study will not only explain how these RPE65 mutations impair vision in patients with retinal dystrophies, but also provide clues for future structure-function studies of RPE65, a crucial enzyme for the retinoid visual cycle and normal vision.
